Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until June 25, 2012 to file lead plaintiff applications in a securities class action lawsuit against Accretive Health, Inc. (NYSE: AH), if they purchased the Company’s common stock during the period between March 2, 2011 and April 24, 2012 (the "Class Period"). This action is pending in the United States District Court for the Northern District of Illinois.

What You May Do

If you purchased shares of Accretive Health and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, e-mail or call KSF Managing Partner, Lewis Kahn (lewis.kahn@ksfcounsel.com), toll free, 877-515-1850, or via cell phone any time at 504-301-7900, or KSF Director of Client Relations, Neil Rothstein, Esq. (neil.rothstein@ksfcounsel.com), toll free at 877-694-9510, or via cell phone any time at 330-860-4092. If you wish to serve as a lead plaintiff in this class action by overseeing lead counsel with the goal of obtaining a fair and just resolution, you must request this position by application to the Court by June 25, 2012.

About the Lawsuit

Accretive Health and certain of its senior executives are charged with issuing a series of materially false and misleading statements, during the Class Period, in violation of federal securities laws.

April 25, 2012, shares of Accretive Health declined over 40%, or $7.63 per share, to close at $10.86 per share. That day, the Minnesota Attorney General released a report which demonstrated that Accretive Health used illegal and overly aggressive collection methods to obtain hospital payments from patients.

About Kahn Swick & Foti, LLC

To learn more about KSF, whose partners include the Former Louisiana Attorney General, Charles C. Foti, Jr., and other lawyers with significant experience litigating complex securities class actions nationwide on behalf of both institutional and individual shareholders, you may visit www.ksfcounsel.com.